PT1755391E
(en )
2016-02-03
Methods and compositions for treating neuropathies
EP2671581B8
(en )
2019-11-13
Compositions and methods for treating cancer
EP1737482A4
(en )
2010-09-15
Compositions and methods for treating diseases
IL181896A0
(en )
2007-07-04
Methods and compositions for the treatment of hyperlipidemia
IL176259A0
(en )
2006-10-05
Compositions and methods for treating diabetes
AU2003230750A1
(en )
2003-10-13
Compositions and methods for treating cancer
AU2003225535A1
(en )
2003-09-02
Methods and compositions for treating cancer
WO2006121421A8
(en )
2007-01-11
Methods and formulations for treating glaucoma
IL176919A0
(en )
2006-12-10
Methods and compositions for treating cancer
ZA200703087B
(en )
2009-04-29
Methods and compositions for the treatment of hyperlipidemia
GB0403008D0
(en )
2004-03-17
Composition and method
AU2003298708A1
(en )
2004-06-23
GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER
HK1096031A
(en )
2007-05-25
Compositions and methods for treating contracture
GB0403696D0
(en )
2004-03-24
Process and composition
AU2012258341A1
(en )
2012-12-20
Methods and compositions for treating conditions
EP1796712A4
(en )
2009-11-11
Methods and compositions for treating hypercholesterolemia
IL163878A0
(en )
2005-12-18
Compositions and methods for treating mdma-inducedtoxicity
HK1110303A
(en )
2008-07-11
Methods and compositions for treating cancer
AU2003295604A1
(en )
2004-06-03
Gpc15: methods and compositions for treating cancer
HK1107578A
(en )
2008-04-11
Compositions and methods for treating hyperproliferative disorders
HK1113076A
(en )
2008-09-26
Methods and compositions for treating pain
HK1117032A
(en )
2009-01-09
Methods and compositions for treating pain
AU2003906810A0
(en )
2004-01-08
Methods and compositions for treating inflammatory conditions
HK1087345A
(en )
2006-10-13
Compositions and methods for treating cancer
HK1108133A
(en )
2008-05-02
Methods and compositions for treating or preventing cancer